应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06160 百济神州
已收盘 02-05 16:08:28
209.600
-2.000
-0.95%
最高
211.200
最低
205.000
成交量
445.35万
今开
209.000
昨收
211.600
日振幅
2.93%
总市值
3,230亿
流通市值
2,989亿
总股本
15.41亿
成交额
9.27亿
换手率
0.31%
流通股本
14.26亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 百济神州 02月04日卖空量成交20.03万股,卖空比例为6.33%
市场透视 · 02-04 16:30
每日卖空追踪 | 百济神州 02月04日卖空量成交20.03万股,卖空比例为6.33%
百济神州盘中异动 下午盘大幅上涨3.01%
市场透视 · 02-04 14:10
百济神州盘中异动 下午盘大幅上涨3.01%
百济神州涨4.29% 股价突破200港元大关
市场透视 · 02-03 09:30
百济神州涨4.29% 股价突破200港元大关
每日卖空追踪 | 百济神州 02月02日卖空量成交22.27万股,卖空比例为6.47%
市场透视 · 02-02
每日卖空追踪 | 百济神州 02月02日卖空量成交22.27万股,卖空比例为6.47%
百济神州 ≈ 信达生物+科伦博泰+康方生物 ?
医药财经 · 02-02
百济神州 ≈ 信达生物+科伦博泰+康方生物 ?
每周股票复盘:百济神州(688235)授出273,442股普通股受限制股份单位
证券之星 · 02-01
每周股票复盘:百济神州(688235)授出273,442股普通股受限制股份单位
百济神州(06160)授出涉及2.1万股美国存托股份的受限制股份单位
智通财经网 · 01-30
百济神州(06160)授出涉及2.1万股美国存托股份的受限制股份单位
每日卖空追踪 | 百济神州 01月29日卖空量成交6.94万股,卖空比例为2.08%
市场透视 · 01-29
每日卖空追踪 | 百济神州 01月29日卖空量成交6.94万股,卖空比例为2.08%
百济神州01月29日主力净流出1645.1万元 散户资金买入
市场透视 · 01-29
百济神州01月29日主力净流出1645.1万元 散户资金买入
中国上市、全球首发!百济神州这一创新药开启血液肿瘤治疗新篇章
上观新闻 · 01-28
中国上市、全球首发!百济神州这一创新药开启血液肿瘤治疗新篇章
百济神州盘中异动 临近午盘股价大涨3.07%报208.400港元
市场透视 · 01-28
百济神州盘中异动 临近午盘股价大涨3.07%报208.400港元
上半年封神的医药女神,翻车了
易简财经 · 01-27
上半年封神的医药女神,翻车了
每日卖空追踪 | 百济神州 01月27日卖空量成交10.44万股,卖空比例为3.7%
市场透视 · 01-27
每日卖空追踪 | 百济神州 01月27日卖空量成交10.44万股,卖空比例为3.7%
华福证券:医药生物业新技术全面突破 战略看多中国创新出海
智通财经网 · 01-27
华福证券:医药生物业新技术全面突破 战略看多中国创新出海
2025第十一届中国最具影响力医药企业百强榜发布
江南时报网 · 01-26
2025第十一届中国最具影响力医药企业百强榜发布
每日卖空追踪 | 百济神州 01月26日卖空量成交14.13万股,卖空比例为8.96%
市场透视 · 01-26
每日卖空追踪 | 百济神州 01月26日卖空量成交14.13万股,卖空比例为8.96%
百济神州01月26日主力净流出651.2万元 散户资金买入
市场透视 · 01-26
百济神州01月26日主力净流出651.2万元 散户资金买入
【券商聚焦】招银国际:创新药出海趋势长期将延续
金吾财讯 · 01-26
【券商聚焦】招银国际:创新药出海趋势长期将延续
“从1到N”——百济神州研发体系进化论
E药经理人 · 01-24
“从1到N”——百济神州研发体系进化论
每日卖空追踪 | 百济神州 01月23日卖空量成交14.99万股,卖空比例为5.56%
市场透视 · 01-23
每日卖空追踪 | 百济神州 01月23日卖空量成交14.99万股,卖空比例为5.56%
加载更多
公司概况
公司名称:
百济神州
所属市场:
SEHK
上市日期:
--
主营业务:
BeOne Medicines AG(原名:BeiGene Ltd)是一家全球肿瘤学公司,致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤,致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4(IgG4)抗程序性细胞死亡蛋白1(PD-1)单克隆抗体,具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ(Fcy)受体的结合,帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。
发行价格:
--
{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":209.6,"timestamp":1770278908006,"preClose":211.6,"halted":0,"volume":4453511,"delay":0,"changeRate":-0.00945179584120983,"floatShares":1426000000,"shares":1541000000,"eps":-3.680325627543965,"marketStatus":"已收盘","change":-2,"latestTime":"02-05 16:08:28","open":209,"high":211.2,"low":205,"amount":927316079,"amplitude":0.029301,"askPrice":209.6,"askSize":67300,"bidPrice":209.4,"bidSize":800,"shortable":3,"etf":0,"ttmEps":0.35139337026070516,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770341400000},"marketStatusCode":5,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":211.6,"openAndCloseTimeList":[[1770255000000,1770264000000],[1770267600000,1770278400000]],"volumeRatio":1.155824,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":275.6,"timestamp":1770274800000,"preClose":277.63,"halted":0,"volume":1980000,"delay":0,"premium":"-32.47"},"impliedVol":0.3708,"impliedVolPercentile":0.5714},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2609239759","title":"每日卖空追踪 | 百济神州 02月04日卖空量成交20.03万股,卖空比例为6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609239759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609239759?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193836,"startTime":"0","endTime":"0","summary":"百济神州北京时间02月04日,涨2.82%,卖空量成交20.03万股,较上一交易日减少76.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163814a47b10d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163814a47b10d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1303224171.USD","LU0307460666.USD","BK1588","LU1969619763.USD","LU2328871848.SGD","06160","BK1500","LU1770034418.SGD","LU1251922891.USD","BK1583","LU0588546209.SGD","LU1719994722.HKD","BK1161"],"gpt_icon":0},{"id":"2609539756","title":"百济神州盘中异动 下午盘大幅上涨3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609539756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609539756?lang=zh_cn&edition=full","pubTime":"2026-02-04 14:10","pubTimestamp":1770185448,"startTime":"0","endTime":"0","summary":"2026年02月04日下午盘14时10分,百济神州股票出现波动,股价快速上涨3.01%。截至发稿,该股报212.000港元/股,成交量167.006万股,换手率0.12%,振幅3.60%。机构评级方面,在所有12家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。百济神州股票所在的生物技术行业中,整体涨幅为0.88%。百济神州公司简介:百济神州是一家全球性、商业阶段的生物科技公司,专注于研究、开发、生产以及商业化创新型药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020414104897a4cacf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020414104897a4cacf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","06160","BK1500","LU1969619763.USD","LU0588546209.SGD","BK1588","BK1583","BK1161","LU2328871848.SGD","LU1770034418.SGD","LU1251922891.USD","LU1303224171.USD","LU1719994722.HKD"],"gpt_icon":0},{"id":"2608499688","title":"百济神州涨4.29% 股价突破200港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2608499688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608499688?lang=zh_cn&edition=full","pubTime":"2026-02-03 09:30","pubTimestamp":1770082208,"startTime":"0","endTime":"0","summary":"2026年02月03日早盘09时30分,百济神州股票出现异动,股价大幅拉升4.29%。截至发稿,该股报206.600港元/股,成交量10.22万股,换手率0.01%,振幅0.50%。资金方面,该股资金流入655.218万港元,流出265.854万港元。百济神州股票所在的生物技术行业中,整体涨幅为1.59%。其相关个股中,百济神州、瑞博生物-B、维立志博-B涨幅较大,振幅较大的相关个股有泰格医药、昭衍新药、君实生物,振幅分别为1.52%、1.38%、1.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203093008a6cc2b2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203093008a6cc2b2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06160","LU1303224171.USD","LU0307460666.USD","LU0588546209.SGD","LU1251922891.USD","LU1969619763.USD","BK1161","BK1588","LU2328871848.SGD","LU1770034418.SGD","LU1719994722.HKD","BK1500"],"gpt_icon":0},{"id":"2608884998","title":"每日卖空追踪 | 百济神州 02月02日卖空量成交22.27万股,卖空比例为6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608884998?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021036,"startTime":"0","endTime":"0","summary":"百济神州北京时间02月02日,跌4.11%,卖空量成交22.27万股,较上一交易日减少69.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163749a4728f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163749a4728f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU0307460666.USD","LU0588546209.SGD","LU1770034418.SGD","LU1969619763.USD","BK1583","LU1251922891.USD","LU1719994722.HKD","BK1161","LU2328871848.SGD","BK1588","LU1303224171.USD","BK1500"],"gpt_icon":0},{"id":"2608450810","title":"百济神州 ≈ 信达生物+科伦博泰+康方生物 ?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608450810","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608450810?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:29","pubTimestamp":1770002959,"startTime":"0","endTime":"0","summary":"截止到2026年2月2日午间市值数据显示:百济神州以约3070亿港元的市值,几乎等同于信达生物、科伦博泰生物与康方生物三者的总和。2025年第三季度,百济神州净利润达1.25亿美元,而去年同期为亏损1.21亿美元。信达生物、科伦博泰和康方生物则仍处于高增长、高投入阶段,其估值包含了风险溢价和未来成长潜力。对于信达生物、科伦博泰和康方生物而言,未来18-24个月是关键的验证期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828714.EUR","LU1303224171.USD","LU2399975544.HKD","LU2097828557.USD","BK1589","BK1574","LU2242644610.SGD","LU0348767384.USD","BK1588","LU0196878994.USD","LU0540923850.HKD","06990","LU2097828631.EUR","LU0348784397.USD","LU1720050803.USD","01801","LU2778985437.USD","LU0348735423.USD","LU0348783233.USD","LU0417516571.SGD","LU0588546209.SGD","LU1719994722.HKD","LU2097828474.EUR","BK1583","06160","LU2097828805.USD","LU2476274720.SGD","LU0502904849.HKD","09926","LU0455707207.USD","BK1161","LU0348827113.USD","LU1251922891.USD","IE00B5MMRT66.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU1969619763.USD","LU2328871848.SGD","HK0000165453.HKD","LU0634319403.HKD","LU1794554557.SGD","LU0417516902.SGD","BK1500","LU0417516738.SGD","LU0348825331.USD","LU0561508036.HKD","IE00B543WZ88.USD","LU1961090484.USD","LU0348766576.USD","LU1770034418.SGD"],"gpt_icon":0},{"id":"2608072455","title":"每周股票复盘:百济神州(688235)授出273,442股普通股受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2608072455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608072455?lang=zh_cn&edition=full","pubTime":"2026-02-01 01:43","pubTimestamp":1769881393,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,百济神州报收于277.26元,较上周的289.38元下跌4.19%。本周,百济神州1月29日盘中最高价报292.0元。1月30日盘中最低价报277.12元。百济神州当前最新总市值4271.68亿元,在化学制药板块市值排名1/150,在两市A股市值排名29/5184。授出代价为零,无表现目标及退扣机制。该等单位将在未来四年分批归属,每次归属25%,须持续服务。本次授出后,2016期权及激励计划尚余60,920,391股股份可供授出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1770034418.SGD","BK1583","LU1719994722.HKD","LU1969619763.USD","LU0588546209.SGD","BK1588","06160","LU1251922891.USD","LU1303224171.USD","BK1161","688235","LU2328871848.SGD","BK0239","BK1500","LU0307460666.USD"],"gpt_icon":0},{"id":"2607018875","title":"百济神州(06160)授出涉及2.1万股美国存托股份的受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2607018875","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607018875?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:54","pubTimestamp":1769763247,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)发布公告,于2026年1月23 日,董事会薪酬委员会根据2016期权及激励计划的条款向二百四十六名承授人授出涉及合共2.1万股美国存托股份的受限制股份单位。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1303224171.USD","BK0239","BK4585","BK1588","LU0588546209.SGD","LU1719994722.HKD","688235","BK1583","06160","BK1161","BK4139","LU1251922891.USD","LU1969619763.USD","LU2328871848.SGD","BK4526","BK1500","LU0307460666.USD","ONC","LU1770034418.SGD"],"gpt_icon":0},{"id":"2607080024","title":"每日卖空追踪 | 百济神州 01月29日卖空量成交6.94万股,卖空比例为2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607080024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607080024?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675438,"startTime":"0","endTime":"0","summary":"百济神州北京时间01月29日,跌0.38%,卖空量成交6.94万股,较上一交易日减少86.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164204a6bae580&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164204a6bae580&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1770034418.SGD","BK1500","LU0307460666.USD","06160","BK1583","LU1251922891.USD","LU1719994722.HKD","BK1161","LU0588546209.SGD","LU1303224171.USD","BK1588","LU1969619763.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2607103881","title":"百济神州01月29日主力净流出1645.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607103881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607103881?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:16","pubTimestamp":1769674564,"startTime":"0","endTime":"0","summary":"01月29日, 百济神州股价跌0.38%,报收209.60元,成交金额7.0亿元,换手率0.23%,振幅2.09%,量比1.19。百济神州今日主力资金净流出1645.1万元,上一交易日主力净流入2805.5万元。该股近5个交易日上涨4.70%,主力资金累计净流入1923.7万元;近20日主力资金累计净流出409.7万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162710a463dc20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162710a463dc20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1719994722.HKD","BK1161","LU1770034418.SGD","LU1969619763.USD","BK1588","06160","BK1583","LU0588546209.SGD","LU1303224171.USD","LU2328871848.SGD","BK1500","LU0307460666.USD","LU1251922891.USD"],"gpt_icon":0},{"id":"2606979167","title":"中国上市、全球首发!百济神州这一创新药开启血液肿瘤治疗新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2606979167","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606979167?lang=zh_cn&edition=full","pubTime":"2026-01-28 17:17","pubTimestamp":1769591825,"startTime":"0","endTime":"0","summary":"百济神州新型BCL2抑制剂索托克拉(百悦达)中国上市会暨全球首发盛典日前举行。会上,众多专家共同就国内慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)以及套细胞淋巴瘤(MCL)的诊疗现状、治疗策略及创新诊疗格局展开分享与讨论,以期推动创新药物更好地造福国内患者。近年来,我国血液肿瘤的防治依然面临严峻挑战。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601283633690762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06078","06978","LU0329678170.USD","LU1770034418.SGD","LU0329678337.USD","BK1500","LU1719994722.HKD","LU1303224171.USD","BK0239","LU2488822045.USD","ONC","BK1583","BK4139","06160","BK4526","BK4585","LU1251922891.USD","BK1161","LU0588546209.SGD","LU1969619763.USD","159992","LU2328871848.SGD","LU0307460666.USD","BK1574","BK1209","688235","BK1588","LU0737861772.HKD"],"gpt_icon":0},{"id":"2606761362","title":"百济神州盘中异动 临近午盘股价大涨3.07%报208.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606761362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606761362?lang=zh_cn&edition=full","pubTime":"2026-01-28 11:30","pubTimestamp":1769571052,"startTime":"0","endTime":"0","summary":"2026年01月28日临近午盘11时30分,百济神州股票出现波动,股价大幅上涨3.07%。截至发稿,该股报208.400港元/股,成交量144.803万股,换手率0.10%,振幅3.36%。资金方面,该股资金流入1.59038亿港元,流出9420.53万港元。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。百济神州股票所在的生物技术行业中,整体涨幅为0.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012811305397a3b4b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012811305397a3b4b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU0307460666.USD","LU0588546209.SGD","LU1770034418.SGD","LU1969619763.USD","BK1583","LU1251922891.USD","LU1719994722.HKD","BK1161","LU2328871848.SGD","BK1588","LU1303224171.USD","BK1500"],"gpt_icon":0},{"id":"2606785019","title":"上半年封神的医药女神,翻车了","url":"https://stock-news.laohu8.com/highlight/detail?id=2606785019","media":"易简财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606785019?lang=zh_cn&edition=full","pubTime":"2026-01-27 18:57","pubTimestamp":1769511478,"startTime":"0","endTime":"0","summary":"近期,医药女神们的四季报披露,张韡、赵蓓等人的四季度业绩均陷入亏损。医药女神葛兰,持仓始终集中在大市值医药龙头、CXO和创新药三大主流赛道上。另一医药女神赵蓓,其管理代表作工银前沿医疗A,第四季度增持新诺威、科伦药业,减持药明康德、恒瑞医药,组合更加均衡。第四季度,市场回调后,他集中资金加仓核心标的,大幅增持迪哲医药,同时增持联影医疗、奕瑞科技等高端器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127190423a6b2cab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127190423a6b2cab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02615","02196","09939","BK1515","BK1574","03759","01530","BK1161","03347","02359","06160","BK1141","01276","BK1576"],"gpt_icon":0},{"id":"2606207035","title":"每日卖空追踪 | 百济神州 01月27日卖空量成交10.44万股,卖空比例为3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606207035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606207035?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502639,"startTime":"0","endTime":"0","summary":"百济神州北京时间01月27日,涨0.1%,卖空量成交10.44万股,较上一交易日减少70.35%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164231a45b406c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164231a45b406c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1719994722.HKD","BK1500","LU0588546209.SGD","LU1770034418.SGD","LU1303224171.USD","BK1583","LU0307460666.USD","LU2328871848.SGD","06160","LU1251922891.USD","LU1969619763.USD","BK1161","BK1588"],"gpt_icon":0},{"id":"2606272282","title":"华福证券:医药生物业新技术全面突破 战略看多中国创新出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2606272282","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606272282?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:01","pubTimestamp":1769482871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,华福证券发布研报称,2025年中国创新药全球竞争力凸显,出海交易创新高,多家企业扭亏为盈。战略看多中国创新出海。华福证券主要观点如下:国内复盘:全球竞争力凸显,企业扭亏为盈+管线出海价值新高度2025创新药指数大涨,Biopharma和Biotech持仓比例显著提升,核心驱动因素是中国创新药全球竞争力凸显。创新药市场份额快速提升,肿瘤与免疫领域创新药份额超32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02615","BK1161","01276","BK1574","06160","06978","09606","09926","06938","01093","02096","09887","BK1593","HK0000165453.HKD","02157","BK1583","02162","01801","01530","01672","06955"],"gpt_icon":0},{"id":"2606758216","title":"2025第十一届中国最具影响力医药企业百强榜发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758216","media":"江南时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606758216?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:16","pubTimestamp":1769418960,"startTime":"0","endTime":"0","summary":"2026年1月26日,由董事会网、亚布力智库联合主办的“2025第十一届中国最具影响力医药企业百强榜”正式揭晓。在医药产业从“规模扩张”向“创新驱动”转型的关键期,本届百强榜的发布具有多重行业价值,成为解读中国医药产业格局的重要窗口。从本届榜单不难看出,中国医药产业正呈现“创新集聚、分化加剧、区域协同”的发展趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02607","01477","06821","BK1191","00460","01530","02196","03692","BK1515","02315","BK1574","06160","09939","01801","02615","BK1161","00874","01276"],"gpt_icon":0},{"id":"2606924929","title":"每日卖空追踪 | 百济神州 01月26日卖空量成交14.13万股,卖空比例为8.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606924929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606924929?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416237,"startTime":"0","endTime":"0","summary":"百济神州北京时间01月26日,跌1.08%,卖空量成交14.13万股,较上一交易日减少64.43%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164258a456cbaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164258a456cbaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU0307460666.USD","LU1719994722.HKD","LU2328871848.SGD","06160","LU1770034418.SGD","BK1583","LU0588546209.SGD","LU1251922891.USD","BK1161","BK1500","LU1303224171.USD","LU1969619763.USD"],"gpt_icon":0},{"id":"2606251249","title":"百济神州01月26日主力净流出651.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606251249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606251249?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:16","pubTimestamp":1769415370,"startTime":"0","endTime":"0","summary":"01月26日, 百济神州股价跌1.08%,报收202.00元,成交金额3.2亿元,换手率0.11%,振幅1.47%,量比0.62。百济神州今日主力资金净流出651.2万元,上一交易日主力净流入2757.7万元。该股近5个交易日上涨1.50%,主力资金累计净流入90.0万元;近20日主力资金累计净流入3564.1万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126162615a6ad67f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126162615a6ad67f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU0307460666.USD","LU1719994722.HKD","LU2328871848.SGD","06160","LU1770034418.SGD","BK1583","LU0588546209.SGD","LU1251922891.USD","BK1161","BK1500","LU1303224171.USD","LU1969619763.USD"],"gpt_icon":0},{"id":"2606326296","title":"【券商聚焦】招银国际:创新药出海趋势长期将延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2606326296","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606326296?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:17","pubTimestamp":1769404672,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示,MSCI中国医疗指数2026年初至今累计上涨9.2%,跑赢MSCI中国指数5.6%。展望2026年,创新药出海趋势长期将延续,该机构将重点关注已出海管线的临床进展与数据兑现的核心催化。年初多个创新药BD交易落地,中国创新药出海的趋势向好。该机构认为,中国企业对于临床前分子的转让或将谨慎,未来中国出海分子将大多在具备中国早期临床试验数据的基础上达成,以获得更高的交易价值。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973928","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","IE00B5MMRT66.SGD","LU1226287875.USD","SG9999002562.SGD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0315179316.USD","LU0417516902.SGD","09926","02269","LU2399975544.HKD","02142","LU1794554557.SGD","01801","BK1588","LU0708995583.HKD","LU1303224171.USD","06185","LU1226287529.USD","LU3063872942.SGD","09688","01093","LU0348767384.USD","SG9999002463.SGD","LU1969619763.USD","LU0516423091.SGD","01877","IE00B031HY20.USD","LU0043850808.USD","06160","LU0348784397.USD","LU0456827905.SGD","LU1880383366.USD","LU0348825331.USD","LU0359201612.USD","09995","159992","LU0979878070.USD","IE00BZ08YS42.EUR","LU0051755006.USD","LU0588546209.SGD","06978","LU0516422440.USD","LU0516422952.EUR","LU1807302812.USD","01177","LU2242644610.SGD","LU1242518931.SGD","BK1500","02616"],"gpt_icon":0},{"id":"2606253412","title":"“从1到N”——百济神州研发体系进化论","url":"https://stock-news.laohu8.com/highlight/detail?id=2606253412","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606253412?lang=zh_cn&edition=full","pubTime":"2026-01-24 10:30","pubTimestamp":1769221852,"startTime":"0","endTime":"0","summary":"它,是“从1到N”的起点。所言非虚,百济神州确实像个“研发狂魔”。但百济神州总裁、全球研发负责人汪来博士认为,索托克拉的意义远不止如此。2025年12月30日,索托克拉获批,这款被寄予厚望的产品让百济神州完成了这场历时六年多的模式验证。“百济神州通过系统梳理BTK耐药的作用机制,逐一排查潜在方向,最终锚定BCL2。”2019年,汪来接手百济神州全部早研团队。这是百济神州整个研发流程中审核最严苛的一环。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124103520a4503c6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124103520a4503c6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU0307460666.USD","LU0588546209.SGD","LU1770034418.SGD","LU1969619763.USD","BK1583","LU1251922891.USD","LU1719994722.HKD","BK1161","LU2328871848.SGD","BK1588","LU1303224171.USD","BK1500"],"gpt_icon":0},{"id":"2605288188","title":"每日卖空追踪 | 百济神州 01月23日卖空量成交14.99万股,卖空比例为5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605288188","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605288188?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157037,"startTime":"0","endTime":"0","summary":"百济神州北京时间01月23日,涨2.2%,卖空量成交14.99万股,较上一交易日减少75.89%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164109a6a44eb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164109a6a44eb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU1251922891.USD","LU1719994722.HKD","LU0307460666.USD","LU1969619763.USD","LU1303224171.USD","LU0588546209.SGD","06160","BK1500","LU1770034418.SGD","LU2328871848.SGD","BK1161","BK1588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":0.089},{"period":"3month","weight":0.122},{"period":"6month","weight":0.2353},{"period":"1year","weight":0.5289},{"period":"ytd","weight":0.1801}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG(原名:BeiGene Ltd)是一家全球肿瘤学公司,致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤,致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4(IgG4)抗程序性细胞死亡蛋白1(PD-1)单克隆抗体,具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ(Fcy)受体的结合,帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.625,"avgChangeRate":0.043803},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.052519},{"month":4,"riseRate":0.428571,"avgChangeRate":0.037509},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.052709},{"month":6,"riseRate":0.428571,"avgChangeRate":0.007027},{"month":7,"riseRate":0.857143,"avgChangeRate":0.097108},{"month":8,"riseRate":0.857143,"avgChangeRate":0.058603},{"month":9,"riseRate":0.5,"avgChangeRate":0.025162},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}